As of August 6, over 100 A-share listed companies in the entire market have disclosed their 2026 semi-annual reports. According to the data, among the top ten shareholders of listed companies such as Zejing Pharmaceutical, Shijia Photonics, Dingtong Technology, and HKUST Intelligence, public fund products occupy half or more of the seats. Some fund sources have analyzed that large purchases until they become the top ten shareholders of listed companies are often particularly optimistic about the performance of this investment opportunity. What are the factors that make products owned by various public funding agencies enter the market at the same time? Judging from the semi-annual report results, these companies generally showed the characteristics of high net profit growth or entering an inflection point in profit. This coincides with the aesthetic growth investment style that the public equity industry has valued in recent years.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.